Cabergoline may act as a radioprotective agent in Cushing's disease
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Endocrinology"
DOI: 10.1111/cen.14123
Abstract: Conventional fractionated radiotherapy (CRT) achieves control of pathological hypercortisolism in 75%‐80% of patients with persistent or recurrent Cushing's disease (CD), over a mean period of 18‐24 months. Medical therapy is recommended as bridge therapy while… read more here.
Keywords: cushing disease; act radioprotective; agent cushing; radioprotective agent ... See more keywords
Molecular Hydrogen as a Potential Clinically Applicable Radioprotective Agent
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms22094566
Abstract: Although ionizing radiation (radiation) is commonly used for medical diagnosis and cancer treatment, radiation-induced damages cannot be avoided. Such damages can be classified into direct and indirect damages, caused by the direct absorption of radiation… read more here.
Keywords: molecular hydrogen; hydrogen potential; clinically applicable; radioprotective agent ... See more keywords